動物用抗菌薬および抗生物質の世界市場:水産動物、家畜、コンパニオンアニマル用薬

◆英語タイトル:Global Animal Antimicrobials and Antibiotics Market 2015-2019
◆商品コード:IRTNTR5995
◆発行会社(調査会社):Technavio
◆発行日:2015年6月3日
◆ページ数:69
◆レポート言語:英語
◆レポート形式:pdf
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥333,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、動物用抗菌薬および抗生物質の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、動物用抗菌薬および抗生物質の世界市場規模及び予測、種類別分析、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
【レポートの概要】

About Animal Antimicrobials and Antibiotics
Companion animals such as swine, cattle, horses, and fish are prone to various kinds of infections. Antimicrobials and antibiotics are used to treat these infections. Farm owners also use these drugs to accelerate the growth of animals, especially in the farms of North America and Europe. Similar to medicines used by humans, animal antimicrobials and antibiotics require authorization from the governments of the countries where it is being marketed. Lack of adherence to guidelines on antibiotic usage on farm animals can lead to over-use of antibiotics and result in drug-resistant strains of microorganisms. These can then be transferred to human beings through consumption of milk or meat.
Technavio’s analysts forecast the global animal antimicrobials and antibiotics market to grow at a CAGR of 5.25% over the period 2014-2019.

[Covered in this Report]
This report covers the present scenario and the growth prospects of the global animal antimicrobials and antibiotics market for the period 2015-2019. To calculate the market size, the report considers revenue generated through sales of various antibiotics and antimicrobials intended for use in animals.
Based on the chemical class of the drugs, the global animal antimicrobials and antibiotics market can be classified into the following:
• Tetracylines
• Penicillins
• Sulfonamides
• Macrolides
• Aminoglycosides
• Cephalosporins
• Others

The global animal antimicrobials and antibiotics market can be classified based on the type of animal on which the drugs are used. These include:
• Aquatic animals (fish, molluscs, or crustaceans)
• Farm animals (cattle, sheep, goats, poultry, and pigs)
• Companion animals (horses, cats, and dogs)

The report also presents the vendor landscape and a corresponding detailed analysis of the top five vendors in the global animal antimicrobials and antibiotics market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

Technavio’s report, Global Animal Antimicrobials and Antibiotics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and EMEA and APAC; it also covers the global animal antimicrobials and antibiotics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• Bayer
• Elanco
• Merck Animal Health
• Merial
• Zoetis

[Other Prominent Vendors]
• Animal Medics
• Biogenesis Bago
• Biovet
• Boehringer Ingelheim
• Ceva Holdings
• Dechra Pharmaceuticals
• ECO Animal Health
• Huvepharma
• Indian Immunologicals
• Lillidale Animal Health
• Mobedco (The Arab Pesticides & Veterinary Drugs)
• Neogen
• Norbrook
• Orion
• Phibro Animal Health
• Vétoquinol
• Virbac
• Vitafor

[Market Driver]
• Demand for non-vegetarian protein-rich diet
• For a full, detailed list, view our report

[Market Challenge]
• Lengthy and expensive regulatory approval processes
• For a full, detailed list, view our report

[Market Trend]
• Increase in M&A
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【レポートの目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Veterinary Drug Approval Process

07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis

08.Market Segmentation by Chemical Class
08.1 Tetracyclines
08.2 Penicillins
08.3 Sulfonamides
08.4 Macrolides
08.5 Aminoglycosides
08.6 Cephalosporins
08.7 Others

09.Market Segmentation by Type of Animal
09.1 Aquatic Animals
09.2 Farm Animals
09.3 Companion Animals

10.Geographical Segmentation
10.1 Global Animal Antimicrobials and Antibiotics Market by Geographical Segmentation 2014-2019
10.2 Animal Antimicrobials and Antibiotics Market in Americas
10.2.1 Market Size and Forecast
10.3 Animal Antimicrobials and Antibiotics Market in EMEA
10.3.1 Market Size and Forecast
10.3.2 Animal Antimicrobials and Antibiotics Market in APAC Market Size and Forecast

11.Buying Criteria

12.Market Growth Drivers

13.Drivers and their Impact

14.Market Challenges

15.Impact of Drivers and Challenges

16.Market Trends

17.Trends and their Impact

18.Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2014
18.2.1 Zoetis
18.2.2 Merck Animal Health
18.2.3 Merial
18.2.4 Elanco
18.2.5 Bayer
18.3 Other Prominent Vendors

19.Key Vendor Analysis
19.1 Bayer
19.1.1 Key facts
19.1.2 Business Overview
19.1.3 Business segmentation by revenue 2014
19.1.4 Business segmentation by revenue 2013 and 2014
19.1.5 Geographical segmentation by revenue 2014
19.1.6 Business strategy
19.1.7 Recent developments
19.1.8 SWOT analysis
19.2 Elanco Animal Health
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Strategy
19.2.4 Recent Developments
19.2.5 SWOT Analysis
19.3 Merck Animal Health
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Strategy
19.3.4 Recent Developments
19.3.5 SWOT Analysis
19.4 Merial
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Strategy
19.4.4 Recent Developments
19.4.5 SWOT Analysis
19.5 Zoetis
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Business Segmentation by Revenue 2013
19.5.4 Business Segmentation by Revenue 2012 and 2013
19.5.5 Geographical Segmentation by Revenue 2013
19.5.6 Business Strategy
19.5.7 Recent Developments
19.5.8 SWOT Analysis

20.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Global Animal Antimicrobials and Antibiotics Market 2014-2019 ($ millions)
Exhibit 3: Global Animal Antimicrobials and Antibiotics Market by Chemical Class
Exhibit 4: Global Animal Antimicrobials and Antibiotics Market by Chemical Class 2014
Exhibit 5: Global Animal Antimicrobials and Antibiotics Market by Type of Animal
Exhibit 6: Global Animal Antimicrobials and Antibiotics Market by Geographical Segmentation 2014
Exhibit 7: Global Animal Antimicrobials and Antibiotics Market by Geographical Segmentation 2019
Exhibit 8: Animal Antimicrobials and Antibiotics Market in Americas 2014-2019 ($ millions)
Exhibit 9: Animal Antimicrobials and Antibiotics Market in EMEA 2014-2019 ($ millions)
Exhibit 10: Animal Antimicrobials and Antibiotics Market in APAC 2014-2019 ($ millions)
Exhibit 11: Revenue Comparison of the Major Vendors in the Global Animal Antimicrobials and Antibiotics market 2014 ($ millions)
Exhibit 12: Bayer: Business segmentation by revenue 2014
Exhibit 13: Bayer: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 14: Bayer: Geographical segmentation by revenue 2014
Exhibit 15: Zoetis: Business Segmentation by Revenue 2013
Exhibit 16: Zoetis: Business Segmentation by Revenue 2012 and 2013 ($ billions)
Exhibit 17: Zoetis: Geographical Segmentation by Revenue 2013



【掲載企業】

Bayer, Elanco, Merck Animal Health, Merial, Zoetis, Animal Medics, Biogenesis Bago, Biovet, Boehringer Ingelheim, Ceva Holdings, Dechra Pharmaceuticals, ECO Animal Health, Huvepharma, Indian Immunologicals, Lillidale Animal Health, Mobedco (The Arab Pesticides & Veterinary Drugs), Neogen, Norbrook, Orion, Phibro Animal Health, Vétoquinol, Virbac,Vitafor

【レポートのキーワード】

動物用抗菌薬、動物用抗生物質、水産動物、家畜、コンパニオンアニマル(伴侶動物)、製薬、医療、ペット、テトラサイクリン、ペニシリン、スルホンアミド、マクロライド、アミノグリコシド、セファロスポリン

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[動物用抗菌薬および抗生物質の世界市場:水産動物、家畜、コンパニオンアニマル用薬]販売に関する免責事項
★調査レポート[動物用抗菌薬および抗生物質の世界市場:水産動物、家畜、コンパニオンアニマル用薬]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆